Key Takeaways
- • Brown University's Center for Advancing Health Policy through Research launched an interactive Private Equity State Tracker on September 8, 2026, mapping over 6,000 private equity healthcare investments across all 50 states from 2015 to 2023, including physician practices and hospital acquisitions.
- • The tracker addresses a critical data gap: private equity deals typically remain undisclosed due to transaction privacy and limited regulatory oversight, forcing researchers and policymakers to rely on fragmented commercial databases and manual research.
- • Users can filter investments by state, county, ZIP code, medical specialty (primary care, orthopedics, oncology, etc.), and temporal trends, enabling granular analysis of private equity penetration in specific healthcare markets.
- • The tool reveals an inverse correlation between private equity activity and hospital employment of physicians—states with higher rates of hospital-employed doctors show less private equity involvement, while states with lower employment rates show greater private equity investment.
- • The tracker's architecture is designed to shift healthcare policy debate from ideological positioning toward evidence-based regulation, addressing corporatization as a systemic phenomenon rather than private equity in isolation.
Summary
Brown University's Center for Advancing Health Policy through Research has deployed a comprehensive interactive mapping tool to address a longstanding information asymmetry in healthcare private equity investment. Launched on September 8, 2026, the Private Equity State Tracker consolidates data on more than 6,000 private equity transactions spanning the period from 2015 to 2023 across all 50 U.S. states, encompassing acquisitions of physician practices, hospitals, and related healthcare assets.
The tool emerges from a critical gap in public data infrastructure. According to Yashaswini Singh, an assistant professor of health services, policy and practice at Brown who helped develop the tracker, private equity transactions in healthcare remain largely undisclosed due to the confidential nature of private market activity and the absence of comprehensive regulatory disclosure requirements. This opacity has forced researchers, policymakers, and journalists to assemble fragmented information from commercial databases and time-intensive manual research, resulting in incomplete market visibility.
The tracker's architecture enables multi-dimensional analysis of private equity activity. Users can disaggregate investments by geographic level (state, county, ZIP code), medical specialty (primary care, orthopedics, oncology), and temporal patterns, allowing stakeholders to identify concentration and evolution of private equity presence within specific healthcare markets and physician segments. This granularity supports identification of regional and specialty-specific trends.
Early analysis from the tracker reveals a substantive correlation between market structure and private equity investment patterns. The data demonstrates an inverse relationship between the prevalence of hospital-employed physicians and private equity investment levels—states with higher concentrations of hospital-employed physicians exhibit lower private equity activity, while states with fewer hospital-employed physicians show greater private equity engagement.
Singh has articulated the tracker's policy objective as shifting healthcare corporatization discourse from ideological positioning toward evidence-based regulatory design. By providing empirical visibility into private equity activity as one channel among multiple forms of healthcare corporatization, the tool aims to prevent regulatory approaches that target private equity in isolation while alternative consolidation mechanisms expand to fill regulatory gaps.
The tool emerges from a critical gap in public data infrastructure. According to Yashaswini Singh, an assistant professor of health services, policy and practice at Brown who helped develop the tracker, private equity transactions in healthcare remain largely undisclosed due to the confidential nature of private market activity and the absence of comprehensive regulatory disclosure requirements. This opacity has forced researchers, policymakers, and journalists to assemble fragmented information from commercial databases and time-intensive manual research, resulting in incomplete market visibility.
The tracker's architecture enables multi-dimensional analysis of private equity activity. Users can disaggregate investments by geographic level (state, county, ZIP code), medical specialty (primary care, orthopedics, oncology), and temporal patterns, allowing stakeholders to identify concentration and evolution of private equity presence within specific healthcare markets and physician segments. This granularity supports identification of regional and specialty-specific trends.
Early analysis from the tracker reveals a substantive correlation between market structure and private equity investment patterns. The data demonstrates an inverse relationship between the prevalence of hospital-employed physicians and private equity investment levels—states with higher concentrations of hospital-employed physicians exhibit lower private equity activity, while states with fewer hospital-employed physicians show greater private equity engagement.
Singh has articulated the tracker's policy objective as shifting healthcare corporatization discourse from ideological positioning toward evidence-based regulatory design. By providing empirical visibility into private equity activity as one channel among multiple forms of healthcare corporatization, the tool aims to prevent regulatory approaches that target private equity in isolation while alternative consolidation mechanisms expand to fill regulatory gaps.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.